Legal Opinion
McDowell v. Eli Lilly & Co.
District Court, S.D. New York
Decided November 7, 2014No. 13 Civ. 3786PublishedCited by 12 opinions
1Opinion of the Court
OPINION
SWEET, District Judge.
Defendant Eli Lilly and Company (“Eli Lilly” or the “Defendant”) has moved pursuant to Federal Rule of Civil Procedure 56 for summary judgment dismissing the failure-to-warn diversity action brought by the plaintiff Jesse McDowell (“McDowell” or the “Plaintiff”). Based upon the-facts and conclusions set forth below, the Defendant’s motion is granted and the action is dismissed.
Prior Proceedings
The Plaintiff filed his complaint on June 4, 2013 alleging that the Defendant’s label-ling for its anti-depression drug Cymbalta. failed to warn adequately about the risk of…
2Cases cited27 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Jose GOENAGA, Plaintiff-Appellant, v. MARCH OF DIMES BIRTH DEFECTS FOUNDATION, Defendant-AppelleeCourt of Appeals for the Second Circuit · 1995
- Richard S. RASKIN, Plaintiff-Appellant, v. the WYATT COMPANY, Defendant-AppelleeCourt of Appeals for the Second Circuit · 1997
- Jaramillo v. Weyerhaeuser Co.Court of Appeals for the Second Circuit · 2008
22 more not listed; retrieve them via the Exa API.
3Cited by12 opinions
- Oden v. Bos. Scientific Corp.District Court, E.D. New York · 2018
- Trisvan v. HeymanDistrict Court, E.D. New York · 2018
- Amos v. Biogen Idec Inc.District Court, W.D. New York · 2017
- Teamsters Local 237 Welfare Fund v. AstraZeneca Pharmaceuticals LPSupreme Court of Delaware · 2016
- Chandler v. Janssen Pharm., Inc.District Court, E.D. New York · 2018
7 more not listed; retrieve them via the Exa API.